Newborn Screening Market Growth Driven by Rising Incidence of Congenital Disorders Technological Advancements and Government Initiatives

"Newborn Screening Market" in terms of revenue was estimated to be worth 935.17 Million in 2022 and is poised to reach 2113.45 Million by the year 2031, growing at a CAGR of 9.8 % from 2023 to 2031 according to a new report by Insight Ace Analytic.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1433

Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Newborn Screening market are:
• An increasing number of newborns
• Increasing prevalence of newborn disorders
• Technical improvements

The following are the primary obstacles to the Newborn Screening market's expansion:
• The lack of uniformity in newborn screening
• High cost associated with newborn screening instruments
• The lack of standardized protocols

Future expansion opportunities for the global Newborn Screening market include:
• Introduction of new advanced technology
• Emerging markets
• Favorable government laws and policies

Key Industry Insights & Findings from the Report:
• The need for newborn screening market is due to rising incidences of congenital diseases, and advancements in technologies for newborn screening.
• The increase in prevalence of congenital illnesses in infants is expected to drive industry growth.
• North America dominated the market and accounted for a revenue share of global revenue in 2023.
• One of the significant concerns restraining industry growth is the high cost related to newborn screening instruments.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Analysis:
The global newborn screening market is anticipated to witness substantial growth, supported by enhanced government initiatives promoting screening programs and continuous advancements in diagnostic technologies. Market expansion is further driven by elevated birth rates and the increasing prevalence of neonatal disorders. Moreover, the rising focus on genetic disorder screening, coupled with growth in emerging markets-characterized by higher birth rates and expanding disposable incomes-offers significant opportunities for industry participants.

List of Prominent Players in the Newborn Screening Market:
• Perkinelmer, Inc.
• Waters Corporation
• Natus Medical Incorporated
• Ab Sciex LLC
• Masimo Corporation
• Bio-Rad Laboratories, Inc.
• Covidien Plc
• Ge Healthcare
• Trivitron Healthcare
• Agilent Technologies Inc.

Recent Developments:
• In August 2022, Trivitron Healthcare launched a Centre of Excellence (CoE) with state-of-the-art R&D and manufacturing facilities at AMTZ Campus, Vishakhapatnam, India, for metabolomics, genomics, newborn screening, and molecular diagnostics.
• In June 2022, Rady Children's Institute for Genomic Medicine introduced a program to advance and evaluate the scalability of a diagnostic and precision medicine guidance tool called BeginNGS to screen newborns for around 400 genetic diseases with known treatment options using rapid whole genome sequencing.
• In June 2022, Novartis AG began with a partnership with the American Society of Hematology (ASH) to supply six additional African nations with the technology that is already being used in Ghana to document and share the diagnosis of babies with sickle cell disease. This partnership expands the current newborn screening consortium to new areas.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1433

Newborn Screening Market Dynamics:
Market Drivers - Increasing Prevalence of Neonatal Disorders:
The rising incidence of neonatal disorders has significantly propelled demand for advanced newborn screening technologies. Conditions such as metabolic, auditory, and hormonal disorders, along with critical congenital heart defects, represent some of the most common neonatal health issues that, if detected early, can be effectively managed.

Enhanced awareness of the benefits of early diagnosis has further bolstered market growth, as screening programs are capable of identifying a broad spectrum of conditions, including congenital hypothyroidism, galactosemia, sickle cell disease, and tyrosinemia. These factors are expected to sustain robust market expansion over the forecast period.

Challenges - High Costs and Regulatory Complexities:
The substantial costs associated with newborn screening equipment present a notable challenge to market growth. In response, key industry stakeholders are prioritizing the development of cost-efficient, safe, and technologically advanced solutions, which may support market progression in the coming years. Furthermore, the absence of standardized regulatory frameworks across regions complicates approval processes, requiring companies to navigate diverse and complex regulatory requirements. These challenges can increase both time and financial burdens, thereby constraining broader market adoption.

Regional Trends - North America Leading Market Growth:
The North American newborn screening market is anticipated to register strong growth, characterized by a high compound annual growth rate (CAGR) throughout the forecast period. Market expansion is driven by factors such as a high prevalence of congenital conditions, supportive government initiatives, well-established healthcare infrastructure, and continuous technological advancements in screening methodologies by regional manufacturers. The United States is projected to retain the largest market share within the region, supported by rising neonatal disorder rates and growing demand for sophisticated screening systems. Additionally, state-level newborn screening programs in the U.S. are expected to further reinforce market development in North America.

Segmentation of Newborn Screening Market-
By Product-
• Instruments
• Reagents
• Assay kits
• Others
By Technology-
• Tandem Mass Spectrometry
• Pulse Oximetry Screening
• Enzyme based Assay
• DNA Assay
• Electrophoresis
• Others
By Test Type-
• Dry Blood Spot Test
• Critical Congenital Heart Diseases
• Hearing Screen
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/global-newborn-screening-market/1433

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.